|
WO2008091770A1
(en)
*
|
2007-01-24 |
2008-07-31 |
Array Biopharma Inc. |
2-aminopyridine derivatives as glucokinase activators
|
|
CA2681695A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Array Biopharma Inc. |
2-aminopyridine analogs as glucokinase activators
|
|
WO2009022171A1
(en)
*
|
2007-08-13 |
2009-02-19 |
Astrazeneca Ab |
Pyridinyiioxy pyridines as alk5 inhibitors
|
|
WO2009022179A2
(en)
*
|
2007-08-14 |
2009-02-19 |
Astrazeneca Ab |
Glucokinase activators in the treatment of osteoarthritis
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP2573087A1
(en)
|
2007-09-21 |
2013-03-27 |
Array Biopharma, Inc. |
Pyridin-2-yl-amino-1,2,4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
|
|
BRPI0818658A2
(pt)
*
|
2007-10-09 |
2015-04-14 |
Merck Patent Ges Mit Beschränkter Haftung |
Derivados de piridina úteis como ativadores de glicoquinase
|
|
JP5693239B2
(ja)
|
2008-01-23 |
2015-04-01 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
４−ピリジノン化合物および癌についてのその使用
|
|
US7741327B2
(en)
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
|
JP2012504591A
(ja)
|
2008-10-02 |
2012-02-23 |
レスピバート・リミテツド |
ｐ３８ＭＡＰキナーゼ阻害剤
|
|
EP2361902A4
(en)
|
2008-11-21 |
2012-04-25 |
Astellas Pharma Inc |
4,6-DIAMINONICOTINSÄUREAMIDVERBINDUNG
|
|
MX2011006219A
(es)
|
2008-12-11 |
2011-06-28 |
Respivert Ltd |
Inhibidores de la proteina cinasa activada por el mitogeno p38.
|
|
GB0905955D0
(en)
|
2009-04-06 |
2009-05-20 |
Respivert Ltd |
Novel compounds
|
|
GB0921730D0
(en)
|
2009-12-11 |
2010-01-27 |
Respivert Ltd |
Method of treatment
|
|
GB0921731D0
(en)
|
2009-12-11 |
2010-01-27 |
Respivert Ltd |
Theraputic uses
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
CN102959076B
(zh)
|
2010-03-31 |
2015-09-16 |
斯克里普斯研究所 |
重编程细胞
|
|
GB201005589D0
(en)
|
2010-04-01 |
2010-05-19 |
Respivert Ltd |
Novel compounds
|
|
US9024041B2
(en)
|
2010-04-08 |
2015-05-05 |
Respivert Ltd. |
P38 MAP kinase inhibitors
|
|
JP5787976B2
(ja)
|
2010-04-08 |
2015-09-30 |
レスピバート・リミテツド |
Ｐ３８ｍａｐキナーゼ阻害剤としてのピラゾリルウレア
|
|
US8178689B2
(en)
|
2010-06-17 |
2012-05-15 |
Hoffman-La Roche Inc. |
Tricyclic compounds
|
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
RU2632900C2
(ru)
*
|
2010-11-19 |
2017-10-11 |
Лиганд Фармасьютикалс Инкорпорейтед |
Гетероциклические амины и их применение
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
JPWO2012121314A1
(ja)
|
2011-03-09 |
2014-07-17 |
第一三共株式会社 |
ジピリジルアミン誘導体
|
|
CN102786517B
(zh)
*
|
2011-05-18 |
2017-06-06 |
中国医学科学院药物研究所 |
Gk和ppar双重激动活性的嘧啶噻唑胺类衍生物
|
|
JP5748210B2
(ja)
*
|
2011-05-26 |
2015-07-15 |
日本化薬株式会社 |
複素環化合物の製造方法
|
|
MX354412B
(es)
|
2011-06-10 |
2018-03-05 |
Merck Patent Gmbh |
Composiciones y metodos para la produccion de compuestos de pirimidina con actividad inhibidora de tirosina cinasa de bruton.
|
|
EP2754654B1
(en)
*
|
2011-09-05 |
2018-05-30 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing coumarin derivative
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
TW201329067A
(zh)
*
|
2011-12-08 |
2013-07-16 |
Amgen Inc |
作為ｇｋａ活化劑之脲化合物
|
|
CA2877026A1
(en)
|
2012-05-18 |
2013-11-21 |
Amgen Inc. |
Method for the preparation of thiadiazoles
|
|
JP6215338B2
(ja)
*
|
2012-11-08 |
2017-10-18 |
ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ |
キナーゼモジュレーターとして有用な二環式ヘテロ環置換ピリジル化合物
|
|
US9732063B2
(en)
|
2012-11-16 |
2017-08-15 |
Respivert Limited |
Kinase inhibitors
|
|
US20160031874A1
(en)
*
|
2013-03-13 |
2016-02-04 |
The Broad Institute, Inc. |
Substituted aminothiazoles for the treatment of tuberculosis
|
|
WO2016001341A1
(en)
*
|
2014-07-03 |
2016-01-07 |
F. Hoffmann-La Roche Ag |
Sulfonylaminopyridine compounds, compositions and methods of use
|
|
CN106749002A
(zh)
*
|
2015-02-12 |
2017-05-31 |
佛山市赛维斯医药科技有限公司 |
一种含硝基喹啉结构的葡萄糖激酶活化剂及其用途
|
|
EP3259256B1
(en)
*
|
2015-02-17 |
2022-03-09 |
Beijing Erai Therapeutics Co., Ltd. |
Compounds and methods for inducing browning of white adipose tissue
|
|
US10807983B2
(en)
|
2015-03-16 |
2020-10-20 |
Ligand Pharmaceuticals, Inc. |
Imidazo-fused heterocycles and uses thereof
|
|
CN114716390A
(zh)
*
|
2015-04-07 |
2022-07-08 |
Ela制药有限公司 |
用于治疗和/或预防细胞或组织坏死的组合物和方法
|
|
JP7062442B2
(ja)
*
|
2015-06-11 |
2022-05-06 |
ユニバーシティ・オブ・ピッツバーグ－オブ・ザ・コモンウェルス・システム・オブ・ハイヤー・エデュケイション |
ｐ６２－ＺＺ化学抑制剤
|
|
EP3390387B1
(en)
|
2015-12-18 |
2021-11-17 |
Bayer Pharma Aktiengesellschaft |
Heteroarylbenzimidazole compounds
|
|
WO2017207534A1
(en)
|
2016-06-03 |
2017-12-07 |
Bayer Pharma Aktiengesellschaft |
Substituted heteroarylbenzimidazole compounds
|
|
US10323036B2
(en)
*
|
2016-10-14 |
2019-06-18 |
Nimbus Lakshmi, Inc. |
TYK2 inhibitors and uses thereof
|
|
WO2020051424A1
(en)
|
2018-09-07 |
2020-03-12 |
Pic Therapeutics |
Eif4e inhibitors and uses thereof
|
|
JP7499284B2
(ja)
*
|
2019-06-25 |
2024-06-13 |
インベンティスバイオ カンパニー リミテッド |
複素環化合物、その製造方法及びその使用方法
|
|
CN110898049B
(zh)
*
|
2019-11-29 |
2021-09-14 |
华中师范大学 |
二硫化合物在制备药物中的应用、fbp酶抑制剂及用于预防和/或治疗糖尿病的药剂
|
|
TW202146393A
(zh)
|
2020-03-03 |
2021-12-16 |
美商皮克醫療公司 |
Eif4e抑制劑及其用途
|
|
WO2022147694A1
(en)
*
|
2021-01-06 |
2022-07-14 |
Beijing Erai Therapeutics Co., Ltd. |
Aminoheteroaryl compounds and uses thereof
|
|
CA3229560A1
(en)
|
2021-08-25 |
2023-03-02 |
Christopher L. Vandeusen |
Eif4e inhibitors and uses thereof
|
|
US12157732B2
(en)
|
2021-08-25 |
2024-12-03 |
PIC Therapeutics, Inc. |
eIF4E inhibitors and uses thereof
|